CN102657737B - Medicament for treating acute gouty arthritis - Google Patents
Medicament for treating acute gouty arthritis Download PDFInfo
- Publication number
- CN102657737B CN102657737B CN 201210075592 CN201210075592A CN102657737B CN 102657737 B CN102657737 B CN 102657737B CN 201210075592 CN201210075592 CN 201210075592 CN 201210075592 A CN201210075592 A CN 201210075592A CN 102657737 B CN102657737 B CN 102657737B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- radix
- gouty arthritis
- acute gouty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating acute gouty arthritis which is prepared from the following materials by weight: 10 to 20 parts of glycyrrhiza, 20 to 30 parts of Fructus Physalis, 10 to 30 parts of angelica root, 20 to 50 parts of net cliffbean, 5 to 15 parts of Salvia, 5 to 15 parts of epimedium, 5 to 10 parts of frankincense, 10 to 20 parts of manyprickle acanthopanax root and10 to 20 parts of polygonum cuspidatum. The medicament for treating acute gouty arthritis described in this invention uses natural medicines, and has advantages of rapid effect, good efficacy and no side-effect.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament for the treatment of acute gouty arthritis.
Background technology
Acute gouty arthritis is long-term crash cry of certain animals metabolism disorder, one group of disease due to urate excretion reduces.The clinical manifestation onset is hurried, and how to open up the toe joint red and swollen heat pain with first is first symptom, peaks in 1 day, and blood uric acid generally raises.
At present, the needs for the medicine for the treatment of acute gouty arthritis constantly strengthen.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of acute gouty arthritis.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of acute gouty arthritis, it is to be made by weight by following bulk drugs: Radix Glycyrrhizae 10-20 part, Calyx seu Fructus physalis 20-30 part, Radix Angelicae Dahuricae 10-30 part, Caulis Spatholobi 20-50 part, Radix Salviae Miltiorrhizae 5-15 part, Herba Epimedii 5-15 part, Olibanum 5-10 part, Radix Et Caulis Acanthopanacis Senticosi 10-20 part and Rhizoma Polygoni Cuspidati 10-20 part.
Preferably, it is to be made by weight by following bulk drugs: 15 parts of 15 parts in Radix Glycyrrhizae, 25 parts of Calyx seu Fructus physaliss, 20 parts of the Radixs Angelicae Dahuricae, 30 parts of Caulis Spatholobis, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Herba Epimedii, 8 parts of Olibanums, 15 parts of Radix Et Caulis Acanthopanacis Senticosis and Rhizoma Polygoni Cuspidati.
Preferably, described medicament is tablet, dispersible tablet, instant, powder or granule.
The medicament for the treatment of acute gouty arthritis of the present invention uses natural drug, so its advantage that has instant effect, good effect, has no side effect.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Extracting liquorice 150 grams, Calyx seu Fructus physalis 250 grams, the Radix Angelicae Dahuricae 200 grams, Caulis Spatholobi 300 grams, Radix Salviae Miltiorrhizae 100 grams, Herba Epimedii 100 grams, Olibanum 80 grams, Radix Et Caulis Acanthopanacis Senticosi 150 grams and Rhizoma Polygoni Cuspidati 150 grams, pulverize, cross 100 mesh sieves, add sucrose 300 grams then, mixing is packed in 100 bags namely.
Experimental example
Diagnostic criteria
With reference to the diagnostic criteria that American Rheumatism Association 1997 works out, possess 6 persons in 12 of following clinical, laboratory and the X ray examinations: 1) arthritis outbreak more than 1 time; 2) inflammation shows in 1 day and peaks; 3) simple joint morbidity; 4) redness and swelling of joints; 5) first ring toe joint pain or the swelling; 6) the first bad toe joint is involved in one-sided outbreak; 7) osteoarthrosis of staggering is involved in one-sided outbreak; 8) suspicious tophus; 9) hyperuricemia; 10) X-ray film shows joint asymmetry swelling; 11) X-ray film shows that the cortical bone of not accompanying sclerotin the to soak into sample of giving a farfetched interpretation is bright damaged; 12) arthritis is between stage of attack, joint fluid biological culture feminine gender.
Choose patient's 50 examples that meet above-mentioned standard, male 25 examples wherein, women 25 examples; 35～71 years old age, average 52 years old.
Use the powder that makes among the embodiment 1 to treat, wherein one day 2 times, each one bag, treating January is a course for the treatment of.
Curative effect determinate standard
Reference " clinical disease diagnosis is according to curing the improvement standard " (The General Logistics Department of PLA's Ministry of Public Health, clinical disease diagnosis is according to curing improvement standard [M]. and Beijing: the People's Medical Officer Press, 1987:715.) standard in is drafted.Cure: symptom complete obiteration, blood uric acid recover normal.Produce effects: transference cure, blood uric acid recover normal or obviously reduce.Effectively: remission, blood uric acid descends to some extent.Invalid: symptom does not have improvement, the blood uric acid no change.
Through the observation of a course for the treatment of is arranged, find that whole patients all meet the standard of healing.
After treating a course for the treatment of, all the patient is followed up a case by regular visits to weekly, continue half a year, find the sign of recurrence.
Claims (2)
1. medicament for the treatment of acute gouty arthritis, it is characterized in that it is to be made by weight by following bulk drugs: Radix Glycyrrhizae 10-20 part, Calyx seu Fructus physalis 20-30 part, Radix Angelicae Dahuricae 10-30 part, Caulis Spatholobi 20-50 part, Radix Salviae Miltiorrhizae 5-15 part, Herba Epimedii 5-15 part, Olibanum 5-10 part, Radix Et Caulis Acanthopanacis Senticosi 10-20 part and Rhizoma Polygoni Cuspidati 10-20 part.
2. the medicament for the treatment of acute gouty arthritis according to claim 1, it is characterized in that it is to be made by weight by following bulk drugs: 15 parts of 15 parts in Radix Glycyrrhizae, 25 parts of Calyx seu Fructus physaliss, 20 parts of the Radixs Angelicae Dahuricae, 30 parts of Caulis Spatholobis, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Herba Epimedii, 8 parts of Olibanums, 15 parts of Radix Et Caulis Acanthopanacis Senticosis and Rhizoma Polygoni Cuspidati.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210075592 CN102657737B (en) | 2012-03-21 | 2012-03-21 | Medicament for treating acute gouty arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210075592 CN102657737B (en) | 2012-03-21 | 2012-03-21 | Medicament for treating acute gouty arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102657737A CN102657737A (en) | 2012-09-12 |
| CN102657737B true CN102657737B (en) | 2013-10-02 |
Family
ID=46767405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210075592 Expired - Fee Related CN102657737B (en) | 2012-03-21 | 2012-03-21 | Medicament for treating acute gouty arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102657737B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104274538B (en) * | 2014-09-23 | 2017-01-18 | 苏州市天灵中药饮片有限公司 | Traditional Chinese medicine extract for treating gout and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207024C (en) * | 2002-09-08 | 2005-06-22 | 许忠文 | Chinese medicine composite for treating gouty arthropathy |
| CN100443112C (en) * | 2005-12-06 | 2008-12-17 | 成都中汇制药有限公司 | Medicine for treating gout and gout arthritis |
| CN101185730B (en) * | 2006-11-21 | 2010-09-08 | 申海莉 | Ache relieving mixture for treating urarthritis |
| CN101019972A (en) * | 2007-03-14 | 2007-08-22 | 刘树平 | Liquid Chinese medicine for treating rheumatic arthritis and rheumatoil arthritis |
-
2012
- 2012-03-21 CN CN 201210075592 patent/CN102657737B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102657737A (en) | 2012-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101940716A (en) | Medicament for treating diabetic nephropathy | |
| CN101530579B (en) | A pharmaceutical composition for soothing the nerves | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN102657737B (en) | Medicament for treating acute gouty arthritis | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN101284108B (en) | Traditional Chinese medicine combination for curing lumbar disease | |
| CN102697999A (en) | Externally applied Chinese medicine for treating rheumatism | |
| CN103948878B (en) | A kind of Chinese medicine composition for the treatment of osteopathia | |
| CN103301368B (en) | Medicament for treating hyperactivity | |
| CN102302744B (en) | Chinese medicinal preparation for treating chronic cholecystitis | |
| CN104474184B (en) | A kind of drug for treating cough after common cold | |
| CN100534496C (en) | Chinese medicine for treating ischemic necrosis of femoral head | |
| CN105982906A (en) | Application of 20(R)-ginsenoside Rg3 in preparing medicines or health products capable of alleviating or/and treating rheumatoid diseases and medicines | |
| CN104547851B (en) | One treats hypertensive medicine | |
| CN103830684B (en) | One treats menorrheal pharmaceutical composition and application thereof | |
| CN103341126A (en) | Chinese medicine composite for treating chronic gastritis and preparation method thereof | |
| CN108635457A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating constipation | |
| CN103566225B (en) | Medicament for treating gynecological postoperative gastrointestinal dysfunction | |
| CN103705840A (en) | Medicinal composition for treating acute and chronic cholecystitis, and cholelithiasis, and preparation method thereof | |
| CN102657836B (en) | Medicine composition used for treating insomnia | |
| CN104888032B (en) | Diarrhea applies | |
| CN105147971A (en) | Traditional Chinese medicine preparation for treating infantile suppurative tonsillitis | |
| CN104888034B (en) | External application Chinese medicine treats the purposes of diarrhea | |
| CN104523961B (en) | A kind of medicament for the treatment of Functional Constipation in Children | |
| CN104001077A (en) | Traditional Chinese medicine composition for treating urinary tract infection and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG Free format text: FORMER OWNER: PAN QING Effective date: 20141222 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272049 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141222 Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8 Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin Address before: 272049 Department of pharmacy, Jining Second People's Hospital,, 107 Hongxing Road East, Jining, Shandong, Shandong Patentee before: Pan Qing |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131002 Termination date: 20170321 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |